General Information of Drug Transporter (DT)
DT ID DTD0336 Transporter Info
Gene Name SLC38A9
Transporter Name Sodium-coupled neutral amino acid transporter 9
Gene ID
153129
UniProt ID
Q8NBW4
Post-Translational Modification of This DT
Overview of SLC38A9 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-N-glycosylation X-Oxidation X-Phosphorylation X: Amino Acid

N-glycosylation

  Asparagine

          4 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC38A9 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

239

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC38A9 Asparagine 239 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC38A9 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

248

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC38A9 Asparagine 248 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC38A9 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

266

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC38A9 Asparagine 266 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC38A9 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

274

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC38A9 Asparagine 274 has the potential to affect its expression or activity.

Oxidation

  Cystine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC38A9 [2]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

95

Experimental Method

Co-Immunoprecipitation

Detailed Description

Oxidation at SLC38A9 Cystine 95 has the potential to affect its expression or activity.

Phosphorylation

  Serine

        17 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC38A9 [3] , [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

6

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A9 Serine 6 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC38A9 [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

8

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A9 Serine 8 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC38A9 [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

14

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A9 Serine 14 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC38A9 [6]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

32

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A9 Serine 32 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC38A9 [6]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

36

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A9 Serine 36 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC38A9 [7] , [8]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

99

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A9 Serine 99 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence SLC38A9 [7] , [8]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

103

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A9 Serine 103 has the potential to affect its expression or activity.

  PTM Phenomenon 8

Have the potential to influence SLC38A9 [9]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

119

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A9 Serine 119 has the potential to affect its expression or activity.

  PTM Phenomenon 9

Have the potential to influence SLC38A9 [9]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

134

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A9 Serine 134 has the potential to affect its expression or activity.

  PTM Phenomenon 10

Have the potential to influence SLC38A9 [9]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

137

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A9 Serine 137 has the potential to affect its expression or activity.

  PTM Phenomenon 11

Have the potential to influence SLC38A9 [10] , [11]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

307

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A9 Serine 307 has the potential to affect its expression or activity.

  PTM Phenomenon 12

Have the potential to influence SLC38A9 [10] , [11]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

309

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A9 Serine 309 has the potential to affect its expression or activity.

  PTM Phenomenon 13

Have the potential to influence SLC38A9 [10] , [11]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

312

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A9 Serine 312 has the potential to affect its expression or activity.

  PTM Phenomenon 14

Have the potential to influence SLC38A9 [10] , [11]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

321

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A9 Serine 321 has the potential to affect its expression or activity.

  PTM Phenomenon 15

Have the potential to influence SLC38A9 [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

414

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A9 Serine 414 has the potential to affect its expression or activity.

  PTM Phenomenon 16

Have the potential to influence SLC38A9 [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

417

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A9 Serine 417 has the potential to affect its expression or activity.

  PTM Phenomenon 17

Have the potential to influence SLC38A9 [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

421

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A9 Serine 421 has the potential to affect its expression or activity.

  Threonine

          8 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC38A9 [5]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

13

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A9 Threonine 13 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC38A9 [9]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

118

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A9 Threonine 118 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC38A9 [9]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

122

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A9 Threonine 122 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC38A9 [9]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

129

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A9 Threonine 129 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC38A9 [9]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

133

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A9 Threonine 133 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC38A9 [3]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

401

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A9 Threonine 401 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence SLC38A9 [3]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

403

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A9 Threonine 403 has the potential to affect its expression or activity.

  PTM Phenomenon 8

Have the potential to influence SLC38A9 [12]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

537

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A9 Threonine 537 has the potential to affect its expression or activity.

  Tyrosine

          9 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC38A9 [10] , [13]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

70

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A9 Tyrosine 70 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC38A9 [10] , [13]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

71

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A9 Tyrosine 71 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC38A9 [8] , [14]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

96

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A9 Tyrosine 96 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC38A9 [7] , [15]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

98

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A9 Tyrosine 98 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC38A9 [7] , [8]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

105

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A9 Tyrosine 105 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC38A9 [10] , [11]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

324

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A9 Tyrosine 324 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence SLC38A9 [3]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

397

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A9 Tyrosine 397 has the potential to affect its expression or activity.

  PTM Phenomenon 8

Have the potential to influence SLC38A9 [3]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

404

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A9 Tyrosine 404 has the potential to affect its expression or activity.

  PTM Phenomenon 9

Have the potential to influence SLC38A9 [3]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

406

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A9 Tyrosine 406 has the potential to affect its expression or activity.
References
1 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: S38A9_HUMAN)
2 A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging. Cell. 2020 Mar 5;180(5):968-983.e24.
3 Characterization of native protein complexes and protein isoform variation using size-fractionation-based quantitative proteomics. Mol Cell Proteomics. 2013 Dec;12(12):3851-73.
4 Integrative network analysis of signaling in human CD34(+) hematopoietic progenitor cells by global phosphoproteomic profiling using TiO2 enrichment combined with 2D LC-MS/MS and pathway mapping. Proteomics. 2013 Apr;13(8):1325-33.
5 Specificity of Phosphorylation Responses to Mitogen Activated Protein (MAP) Kinase Pathway Inhibitors in Melanoma Cells. Mol Cell Proteomics. 2018 Apr;17(4):550-564.
6 Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
7 HIV-1 Activates T Cell Signaling Independently of Antigen to Drive Viral Spread. Cell Rep. 2017 Jan 24;18(4):1062-1074.
8 Global phosphotyrosine survey in triple-negative breast cancer reveals activation of multiple tyrosine kinase signaling pathways. Oncotarget. 2015 Oct 6;6(30):29143-60.
9 Phosphoproteomics reveals ALK promote cell progress via RAS/ JNK pathway in neuroblastoma. Oncotarget. 2016 Nov 15;7(46):75968-75980.
10 Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
11 Identification of tyrosine-phosphorylated proteins associated with metastasis and functional analysis of FER in human hepatocellular carcinoma cells. BMC Cancer. 2009 Oct 16;9:366.
12 Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach. Anal Chem. 2009 Jun 1;81(11):4493-501.
13 Tyrosine phosphorylated Par3 regulates epithelial tight junction assembly promoted by EGFR signaling. EMBO J. 2006 Nov 1;25(21):5058-70.
14 Quantitative phosphoproteomics analysis reveals a key role of insulin growth factor 1 receptor (IGF1R) tyrosine kinase in human sperm capacitation. Mol Cell Proteomics. 2015 Apr;14(4):1104-12.
15 Ultra-deep tyrosine phosphoproteomics enabled by a phosphotyrosine superbinder. Nat Chem Biol. 2016 Nov;12(11):959-966.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.